Skip to content
777 Sourcing.

Capability

exosome isolation

Suppliers
2
States & provinces
2
Countries
1

2 exosome isolation suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BIOFLUIDICA, INC.

CARY, NC

BioFluidica is a privately held biotechnology and liquid biopsy company that developed the LiquidScan platform, which isolates and analyzes liquid biopsy biomarkers including rare cells, extracellular vesicles (exosomes), and cfDNA on one fully automated platform. LiquidScan combines microfluidics, immunoaffinity chemistries, automation hardware, and workflow optimization. The platform has been clinically tested on nine cancer and prenatal patient samples and is used for research applications. BioFluidica also develops scientific instruments, reagents, a

automation hardwareCTC isolationfetal cell isolationimmunoaffinity chemistriesliquid biopsy analysismicrofluidicsrare cell isolation

Compiled from public sources

EXOCULAR DX INC

CENTENNIAL, CO

ExOcular is developing a portfolio of blood-based multiplex tests that measure disease-specific biomarkers isolated from exosomes to help manage severe eye diseases, initially focusing on diabetic retinopathy and age-related macular degeneration. Its analysis algorithms generate a quantitative Disease Severity Score to support early diagnosis, prognosis, and treatment monitoring. Headquarters and lab are located at the University of Colorado Anschutz Medical Campus.

analysis algorithms generating Disease Severity Scorebiomarker measurementclinical trial enrichmentmultiplex biomarker panelstherapy monitoring

Compiled from public sources

Related capabilities

Other processes offered by the shops that list exosome isolation.

Browse all capabilities